China’s largest medical equipment manufacturer, Mindray Medical International (NYSE: MR) is slated to release its second quarter numbers after the market closes at on August 11, and analyst expectations aren’t exactly rosy. We see little reason at this stage to buck the consensus that Mindray won’t be able to sustain its high growth of years past given the field is becoming increasingly commoditized with competition centered largely on price point.

Sell Mindray Medical International.